Latest News
Vistagen implements stockholder-approved reverse stock split to enhance market position
6 June 2023 - Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company focused on CNS disorders, on Tuesday announced the implementation of a stockholder-approved reverse stock split.This split will consolidate outstanding shares at a...
Sol-Gel Technologies and Searchlight Pharma sign exclusive licensing deals for TWYNEO and EPSOLAY in Canada
6 June 2023 - Israel-based dermatology company Sol-Gel Technologies (NASDAQ: SLGL) and Searchlight Pharma, a Canadian specialty pharmaceutical company, on Tuesday announced exclusive license agreements for the Canadian market for dermatology drugs, T...
Merck's PREVYMIS receives FDA approval for additional indication
6 June 2023 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that the US Food and Drug Administration (FDA) has approved a new indication for PREVYMIS (letermovir) for the prophyl...
OSE Immunotherapeutics highlights positive clinical data on Tedopi at ASCO 2023
6 June 2023 - French biotech company OSE Immunotherapeutics (XPAR: OSE) announced on Tuesday that it presented new data on its most advanced product, Tedopi, at the ASCO 2023 Annual Meeting.Tedopi is an immunotherapy that activates tumour-specific T-...
Transgene and NEC demonstrate new positive data on individualised cancer vaccine TG4050 at ASCO 2023
6 June 2023 - Biotechnology company Transgene (Euronext Paris: TNG) and NEC Corporation (NEC; TSE: 6701), an IT and network technology company, on Tuesday reported the presentation of new immunological data on TG4050, an individualised cancer vaccine...